You are here

  • Home
  • Archive
  • Volume 12, Issue 5
  • The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer

Citation Tools

Article menu
Download PDFPDF
Original Articles
The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Tsuda H, Hashiguchi Y, Nakata S, et al
The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer
International Journal of Gynecologic Cancer 2002;12:435-437.